Jeff Yass’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Jeff Yass's DNTH Position: Q3 2026 in Review
Jeff Yass increased its Dianthus Therapeutics (DNTH) stake by 181% in Q3 2026, buying an estimated $5.67M and bringing the position to 84,861 shares worth $7.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3775.
Jeff Yass first reported a position in DNTH in Q3 2019 and has held it in 19 quarters since. 273 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Jeff Yass held 84,861 shares of Dianthus Therapeutics worth $7.47M as of Q3 2026.
- Jeff Yass bought 54,624 Dianthus Therapeutics shares in Q3 2026, an estimated $5.67M.
- Dianthus Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #3775 holding.
- Jeff Yass first reported a position in Dianthus Therapeutics in Q3 2019 and has held it in 19 quarters since.
- 273 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.